Search

everythinglearnresearchcommunity

for

Search:↓

The TCL1 transgenic mouse model is useful for understanding human B-cell leukemia and testing new treatments.

Blocking TRPV3 may help treat itch in dry skin conditions.

Researchers developed a 3D skin model with its own immune and blood vessel cells to better understand skin health and disease.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

TRPV3 channels are involved in skin processes and are affected by shear stress, influencing itch and mechanotransduction.

A small 3D skin model helps study how immune cells move in the skin.

Transcutaneous vaccination using nanoparticles can enhance immune responses and reduce basal cell carcinomas.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

The study suggests that a specific type of immune cell, memory-like NK cells, may increase during active hair loss in Alopecia areata.

CD8+ T cells drive alopecia areata, while regulatory T cells are protective.

Activating TLR3 boosts autophagy gene expression in skin cells.

KRTAP2-3 could help predict cancer recurrence by identifying specific cancer cells.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

γδ T cells are essential for wound healing after poxvirus infection.

Blocking the CXCR3 receptor reduces T cell accumulation in the skin and prevents hair loss in mice.

CD8+ virtual memory T cells may cause hair loss in alopecia areata.

Certain immune cells may cause hair loss by reacting to stressed hair follicles.

Krt15+ cells in mice can resist radiation, regenerate tissue, and start tumors, suggesting new cancer treatment targets.

Increased Treg cells and IL-10 may help quick recovery in acute diffuse and total alopecia.

CD8+ T cells are involved in alopecia areata and may cause disease relapse.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

The early genes of a specific virus can cause abnormal skin cell growth and hair follicle changes.

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

NKG2D+CD4+ T cells are higher in alopecia areata patients and may be involved in the disease.

HPV8 causes hair follicle stem cells to grow, leading to skin lesions.

TLR3 activation helps improve skin and hair follicle healing in mice.

Lower GATA3 levels in mice help hair regrow by changing certain immune cells.